Literature DB >> 26659009

Clinical outcomes of double membrane peeling with or without simultaneous phacoemulsification/gas tamponade for vitreoretinal-interface-associated (VRI) disorders.

Kshitiz Kumar1, Nisha Chandnani2, Pallavi Raj2, Amar Agarwal2.   

Abstract

The purpose of this study is to evaluate the clinical outcomes of double membrane (ERM & ILM) peeling and the effect of combined cataract surgery and SF6 gas injection in vitreoretinal interface (VRI) disorders. This is a retrospective interventional study. Seventy-two eyes with idiopathic vitreoretinal interface abnormalities that underwent 23 gauge pars plana vitrectomy with "double stain and double peel" technique were reviewed. SD-OCT was used to classify VRI disorders into following 4 groups: 44 in ERM type, 17 in VMTS type, 7 in macular pseudohole (MPH) type, and 4 in lamellar macular hole (LMH) type. ERM was a common association in all types. Mean preoperative BCVA improved from 0.58 ± 0.14 logMAR to 0.27 ± 0.16 logMAR units (p = 0.001). Mean CFT reduced from 409.17 ± 122.31 µm preoperatively to 277.28 ± 0.16 µm postoperatively (p < 0.0001). Among the VRI subtypes, visual improvement was significant except in LMH variety (ERM type, p = 0.0029; VMTS type, p = 0.0281; MPH type, p = 0.05; and LMH type, p = 0.7926). Mean change in CFT from baseline was least in LMH cases (p = 0.0093). There was no significant difference in BCVA and CFT in the group who had combined phacovitrectomy versus pseudophakic group (p > 0.05). Use of intraocular SF6 gas tamponade did not show any added benefits among the groups (p > 0.05). Improvement in foveal contour was seen in all groups. Simultaneous removal of ILM along with ERM during surgery for VRI disorders helps in restoring normal foveal contour with a favorable visual outcome. Combined cataract extraction or use of intraocular SF6 gas injection does not affect the surgical results.

Entities:  

Keywords:  Double membrane peeling; Epiretinal membrane; Lamellar macular hole; Macular pseudohole; Vitreomacular traction syndrome; Vitreoretinal interface

Mesh:

Substances:

Year:  2015        PMID: 26659009     DOI: 10.1007/s10792-015-0162-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  35 in total

1.  Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.

Authors:  Lazaros Konstantinidis; Marouen Berguiga; Evgueny Beknazar; Thomas J Wolfensberger
Journal:  Retina       Date:  2009-09       Impact factor: 4.256

2.  Visual outcome of surgery for epiretinal membranes with macular pseudoholes.

Authors:  P Massin; M Paques; H Masri; B Haouchine; A Erginay; P Blain; A Gaudric
Journal:  Ophthalmology       Date:  1999-03       Impact factor: 12.079

3.  Prognostic factors in vitrectomy for lamellar macular hole assessed by spectral-domain optical coherence tomography.

Authors:  Christopher S Lee; Hyoung J Koh; Hyung T Lim; Kyu S Lee; Sung C Lee
Journal:  Acta Ophthalmol       Date:  2012-05-25       Impact factor: 3.761

4.  Anatomic and functional outcome of triamcinolone-assisted 23-gauge vitrectomy in vitreomacular traction syndrome.

Authors:  Yasin Toklu; Sibel Demirel; Ozge Sarac; Hasan Basri Cakmak; Nurullah Cagıl
Journal:  Semin Ophthalmol       Date:  2012 May-Jul       Impact factor: 1.975

5.  Anatomic and visual outcomes of vitrectomy for vitreomacular traction syndrome.

Authors:  Andre J Witkin; Mark E Patron; Leonardo C Castro; Elias Reichel; Adam H Rogers; Caroline R Baumal; Jay S Duker
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010-05-28

6.  Intracellular events in retinal glial cells exposed to ICG and BBG.

Authors:  Shuhei Kawahara; Yasuaki Hata; Muneki Miura; Takeshi Kita; Akihito Sengoku; Shintaro Nakao; Yasutaka Mochizuki; Hiroshi Enaida; Akifumi Ueno; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

7.  Residual internal limiting membrane in epiretinal membrane surgery.

Authors:  K Kifuku; Y Hata; R-i Kohno; S Kawahara; Y Mochizuki; H Enaida; K-h Sonoda; T Ishibashi
Journal:  Br J Ophthalmol       Date:  2009-02-11       Impact factor: 4.638

8.  [Anatomical and functional repercussions of internal limiting membrane peeling in epiretinal membrane surgery].

Authors:  S Guigou; J-C Courjaret; C Marc; J Benhammar
Journal:  J Fr Ophtalmol       Date:  2012-12-21       Impact factor: 0.818

9.  Idiopathic macular epiretinal membrane surgery with simultaneous internal limiting membrane peeling. The experience of the Fribourg Eye Clinic.

Authors:  Georgios D Panos; Philippe de Gottrau
Journal:  Swiss Med Wkly       Date:  2013-10-25       Impact factor: 2.193

10.  Vitreomacular traction syndrome.

Authors:  Juliana Bottós; Javier Elizalde; J Fernando Arevalo; Eduardo B Rodrigues; Maurício Maia
Journal:  J Ophthalmic Vis Res       Date:  2012-04
View more
  3 in total

Review 1.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

Review 2.  Factors Associated with Anatomic Failure and Hole Reopening after Macular Hole Surgery.

Authors:  Yutong Li; Siyan Jin; Lijun Shi; Hecong Qin; Jinsong Zhao
Journal:  J Ophthalmol       Date:  2021-12-07       Impact factor: 1.909

3.  Vitrectomy for the removal of idiopathic epiretinal membrane with or without internal limiting membrane peeling: a meta-analysis.

Authors:  Eleni Christodoulou; Georgios Batsos; Petros Galanis; Christos Kalogeropoulos; Andreas Katsanos; Yannis Alamanos; Maria Stefaniotou
Journal:  Ther Adv Ophthalmol       Date:  2020-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.